Podcast Episodes
Back to Search
Episode 414: Uromigos score en cáncer de próstata metastasico - más allá de las guías clínicas
Edición especial en castellano con Alfonso Gómez de Liaño y Guillermo de Velasco. David Lorente da su visión sobre el nuevo Uromigos Score, que clasi…
1 year, 5 months ago
Episode 413: The Uromigos Score for Advanced Prostate Cancer
Silke and Chris joins us to discuss our latest 'Uromigos Score' in which experts score the value of treatments for advanced prostate cancer. Several …
1 year, 5 months ago
Episode 410: AUA 2025 - BOND-003 Cohort C: Cretostimogene in BCG-Unresponsive NMIBC
Mark Tyson from Mayo Clinic joins the podcast to discuss this replicating adenovirus and a high CR rate in BCG-unresponsive NMIBC
1 year, 5 months ago
Episode 412: AUA 2025 - TAR-200 Monotherapy in BCG-Unresponsive NMUIBC from SunRISe-1
Joe Jacob joins the show to discuss the longer-term follow up of this cohort from SunRISe-1. We discuss definitions of CR and regulatory issues aroun…
1 year, 5 months ago
Episode 411: Live from EIKCS in Amsterdam - RCC Highlights
Viktor Grunwald joins to discuss the new data session from EIKCS
1 year, 5 months ago
Episode 410: AUA 2025 - BOND-003 Cohort C: Cretostimogene in BCG-Unresponsive NMIBC
Mark Tyson from Mayo Clinic joins the podcast to discuss this replicating adenovirus and a high CR rate in BCG-unresponsive NMIBC
1 year, 6 months ago
Episode 409: AUA 2025 - CREST - BCG +/- Sasanlimab in high-risk NMIBC
Neal Shore joins the show to discuss these exciting data from the American Urological Association Annual Meeting
1 year, 6 months ago
Episode 408: Uromigos Japan - European Delphi Study of mRCCについてdiscussion
今月Eur Urol OncolにPublishされたヨーロッパのエキスパートによるmRCCのコンセンサスについて日本との違いについて深い議論をしました！！
1 year, 6 months ago
Episode 407: Drug Development in China: Part 2 of 2
Part 2 of our series dives deeper into the explosion of ADC clinical drug development in China
1 year, 6 months ago
Episode 406: Drug Development in China: Part 1 of 2
Drs. Dingwei Ye and Yao Zhu from China join the show to talk about drug development in China amid the recent surge of GU clinical trials.
1 year, 6 months ago